Four new directors at TherapeuticsMD
This article was originally published in Scrip
Executive Summary
Specialty pharma company TherapeuticsMD, which focuses on products primarily for the women's healthcare market, has elected four new members to its board of directors: Samuel Greco, currently CEO and director of CareView Communications; Cooper Collins, president, CEO and director of Pernix Therapeutics Holdings; Robert LaPenta, a partner of Aston Capital; and Nicholas Segal, director of Seavest Capital Partners.